v3.22.2.2
Stock-based Compensation (Tables)
6 Months Ended
Jul. 31, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Classification of Stock-based Compensation

The following table presents the classification of stock-based compensation for the periods indicated:

 

 

 

Three Months Ended July 31,

 

 

Six Months Ended July 31,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Stock-based compensation:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

$

362

 

 

$

359

 

 

$

711

 

 

$

682

 

Research and development

 

 

17,883

 

 

 

11,525

 

 

 

35,034

 

 

 

22,719

 

Selling, general and administrative

 

 

8,664

 

 

 

7,488

 

 

 

18,205

 

 

 

14,813

 

Total stock-based compensation

 

$

26,909

 

 

$

19,372

 

 

$

53,950

 

 

$

38,214

 

Weighted-Average Assumptions Used to Estimate Fair Value

The following table sets forth the weighted-average assumptions used to estimate the fair value of stock options and employee stock purchase plan awards for the periods indicated:

 

 

 

Three Months Ended July 31,

 

 

Six Months Ended July 31,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Stock Options:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

 

 

 

50

%

 

 

 

 

 

51

%

Risk-free interest rate

 

 

 

 

 

0.85

%

 

 

 

 

 

0.98

%

Expected term (years)

 

 

 

 

5.06

 

 

 

 

 

5.27

 

Dividend yield

 

 

 

 

 

0

%

 

 

 

 

 

0

%

Employee stock purchase plan awards:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

 

 

 

 

 

 

89

%

 

 

61

%

Risk-free interest rate

 

 

 

 

 

 

 

 

0.86

%

 

 

0.06

%

Expected term (years)

 

 

 

 

 

 

 

0.5

 

 

0.5

 

Dividend yield

 

 

 

 

 

 

 

 

0

%

 

 

0

%

 

Stock Option Activities

The following table summarizes stock option activities for the period indicated:

 

 

 

 

Option Outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Intrinsic

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Value Of

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

 

 

Weighted-

 

 

Average

 

 

Options

 

 

Contractual

 

 

Intrinsic

 

 

 

 

 

 

 

Average

 

 

Grant-date

 

 

Exercised

 

 

Term

 

 

Value

 

 

 

Shares

 

 

Exercise Price

 

 

Fair Value

 

 

(in thousands)

 

 

(in years)

 

 

(in thousands)

 

Outstanding at January 31, 2022

 

 

619,322

 

 

$

40.08

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(64,395

)

 

 

32.20

 

 

 

 

 

 

$

3,878

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(6,323

)

 

 

45.88

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

(518

)

 

 

10.89

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at July 31, 2022

 

 

548,086

 

 

 

40.97

 

 

 

 

 

 

 

 

 

 

4.68

 

 

$

25,303

 

Exercisable at July 31, 2022

 

 

386,400

 

 

$

43.27

 

 

 

 

 

 

 

 

 

 

 

3.59

 

 

$

16,853

 

Restricted Stock Unit Activities

The following table summarizes restricted stock unit activities for the period indicated:

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Grant-Date

 

 

 

Shares

 

 

Fair Value

 

Unvested at January 31, 2022

 

 

2,651,135

 

 

$

85.41

 

Granted

 

 

708,985

 

 

 

85.87

 

Vested

 

 

(995,693

)

 

 

68.42

 

Forfeited

 

 

(61,722

)

 

 

100.28

 

Unvested at July 31, 2022

 

 

2,302,705

 

 

$

92.87